Navigation Links
GranuFlo Lawsuit News: W.Va. Man’s Lawsuit Goes to Federal Court, Rottenstein Law Group LLP Reports
Date:8/8/2013

(PRWEB) August 08, 2013

A West Virginia man’s GranuFlo lawsuit against Fresenius Medical Care Holdings Inc., maker of GranuFlo and NaturaLyte, was removed to federal court on July 23. Plaintiff Phillip Ray Harris alleges that Fresenius sold the two dialysis drugs despite knowing about their dangerous heart side effects, according to court documents, reports GranuFlo and NaturaLyte law firm Rottenstein Law Group LLP.

Shirley Harris, the wife of Phillip, used both GranuFlo and NaturaLyte as part of her dialysis regimen, according to court documents (Phillip Ray Harris v. Fresenius Medical Care Holdings Inc.; 2:13-cv-20858, U.S. District Court for the Southern District of West Virginia). One alleged adverse side effect of the drugs is heart attack, which Phillip alleges his wife suffered from, and later died as a result of, following her use of the drugs.

The removal was ordered because the amount of damages Harris seeks exceeds $75,000 and the plaintiff and defendant are in different states (Harris in West Virginia and Fresenius in Massachusetts), according to the court documents.

“When potential clients call us to discuss GranuFlo lawsuits, they often mention potential heart-related side effects,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “If the plaintiff’s allegations are true in this case, then Fresenius should be held accountable.”

The Rottenstein Law Group LLP encourages those seeking more information on GranuFlo and NaturaLyte lawsuits and side effects to visit its website to download a free brochure.

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clie
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
2. GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
3. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
4. GranuFlo Lawsuits Filed in Wake of GranuFlo and NaturaLyte Recall Mount in State and Federal Courts, Bernstein Liebhard LLP Reports
5. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
6. New Granuflo Cardiac Arrest Lawsuit: Now, AttorneyOne Can Provide Advice
7. GranuFlo Lawsuit News: Bernstein Liebhard LLP Reports on Growing Litigation Surrounding GranuFlo Recall
8. Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama
9. GranuFlo Lawsuits Moving Forward in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
10. GranuFlo Lawsuits Move Forward, as Bernstein Liebhard Notes Issuance of New Order in Federal GranuFlo Recall Litigation
11. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... (PRWEB) March 04, 2015 Alliance Healthcare ... and wellness for those in need in San Diego ... local organizations through its Mission Support Grants program with ... non-profit organizations applied for AHF’s Mission Support Grants program. ... AHF’s board of trustees and program committee, as well ...
(Date:3/4/2015)... Houston, Texas (PRWEB) March 04, 2015 ... blog , Endometriosis can be a painful ... endometrium) starts spreading outside of the uterus leading to ... and their families. Endometriosis can have a terrible effect ... symptoms. It is also the most common cause of ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Organic Valley, the ... brand, today announced its cause campaign to Save the Bros, ... and is making a difference to Bros everywhere. To ... Youtube and Facebook. The video was named Adweek’s best ... in Forbes, Mashable and Digiday, among other media outlets. ...
(Date:3/4/2015)... Springfield, VA (PRWEB) March 04, 2015 ... announce that John Dvorak has joined the ... responsible for charting the technology focus for the company, ... , Mr. Dvorak brings 20 years of experience as ... he served in diverse roles at the FBI including ...
(Date:3/4/2015)... 2015 The Alliance for Regenerative ... its upcoming fifth annual Advanced Therapies Summit next ... event this year will feature five expert-led interactive ... the field’s leading companies and organizations. , ... and clinical researchers from the advanced therapies community ...
Breaking Medicine News(10 mins):Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3
... drug Rimonabant (Acomplia) a selective cannabinoid receptor blocker (CB1), ... Supplementation with 20 milligrams of rimonabant a day resulted ... circumference -- a marker of cardiovascularly dangerous visceral fat. ... prevalence of metabolic syndrome in overweight/obese patients. ...
... benefit more from treatment combining cognitive behavioral therapy with ... physicians. ,Panic disorder is one of the most ... patients meeting the criteria for panic disorder were randomly ... combining medication and up to six sessions of cognitive-behavioral ...
... A new study shows people suffering from the bone-thinning ... having celiac disease //, a condition in which people ... for celiac disease can markedly improve bone mineral density, ... celiac disease also tend to have thinning bones, but ...
... gene variant that may increase the risk of late-onset ... improved understanding of the disease and new prevention and ... that specific changes in the gene in a protein ... Alzheimer’s. ,In previous studies, researchers studied Alzheimer’s patients ...
... chemotherapy (IPHC) and is currently //being considered as the ... treatment are connected to a series of tubes and ... the abdominal cavity for a couple of houirs. ... drug while the direct contact helps kill the carcinogenic ...
... Researchers say they may have discovered a potential form ... ,More than 1 million Americans are estimated to ... forms of inflammatory bowel disease. The conditions, can be ... the digestive tracts. Patients with inflammatory bowel disease suffer ...
Cached Medicine News:
(Date:3/4/2015)... , March 4, 2015 Asterias Biotherapeutics, ... the emerging field of regenerative medicine, today announced that ... will ring The Opening Bell ® of the ... 2015. Asterias began trading as an NYSE MKT listed ... York Stock Exchange is a trusted partner to Asterias ...
(Date:3/4/2015)... OAKS, Calif. , March 4, 2015 ... Board of Directors today declared a $0.79 per share ... will be paid on June 5, 2015, to all ... on May 14, 2015.  About Amgen ... for patients suffering from serious illnesses by discovering, developing, ...
(Date:3/4/2015)... 4, 2015  NxStage Medical, Inc. (Nasdaq: NXTM ... that Jeffrey H. Burbank , Chief Executive Officer, will ... Miami, FL on Wednesday, March 11 th ... the event will be made available at http://ir.nxstage.com ... NxStage NxStage Medical, Inc. (Nasdaq: NXTM ...
Breaking Medicine Technology:Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 2Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 3Amgen Announces 2015 Second Quarter Dividend 2Amgen Announces 2015 Second Quarter Dividend 3NxStage to Present at the Barclays Capital Global Healthcare Conference 2
... Based on its recent analysis of the personal emergency ... with the 2010 North American Frost & Sullivan Award ... BeClose System and its applications in the "aging independently" ... While PERS have provided a health monitoring service for ...
... Inc. (Nasdaq: OPTR ) today announced that the ... the Company,s New Drug Application (NDA) for fidaxomicin for the ... reducing the risk of recurrence when used for treatment of ... for six-month Priority Review, and has assigned a Prescription Drug ...
Cached Medicine Technology:Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America 2Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America 3Frost & Sullivan Recognizes BeClose as a Technology Innovator for 'Aging Independently' in North America 4Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI) 2Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI) 3Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI) 4
Shandon Slide Mailers and Envelopes...
Shandon Stackable Slide Storage Cabinet...
Shandon Slide File Storage System...
Shandon Plastic Slide Boxes...
Medicine Products: